West Virginia SB 672: Requiring parity with non-preferred oral branded antipsychotic agents

Status: To Health and Human Resources (as of 2023-02-17)

State: West Virginia · Session: 2023 · Bill: SB 672

Subjects: Insurance

Sponsors: Phillips

View West Virginia SB 672 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.